Tumor marker screening (carcinoembryonic antigen, Ca125, Ca15–3, Ca 19–9, alpha-fetoprotein, prostate specific antigen) showed slightly elevated CEA of 8.6μg/L and PSA of 4.46μg/L Rest of the markers were negative. This evidence concerns the gene CEACAM5 and neoplasm.